Skip to content

Company information lookup

LIVING CELL TECHNOLOGIES LIMITED (LCT)

Living Cell Technologies: developing cell-based therapies for type 1 diabetes and neurological disorders.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
LCT 0.061 0% 0.062 0.069 0.000 0.000 0.000 0

LIVING CELL TECHNOLOGIES LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code LCT
Securities
Official Listing Date 1 September, 2004
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.lctglobal.com/
Registered Office Address Level 3, Suite 302, 70 Pitt Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone 1300 134 875
Head Office Fax (02) 9233 4497
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Roy Austin (Chairman, Independent Director)
Dr Ken Taylor (CEO)
Mr Robert Elliott (Executive Director)
Mr Laurie Hunter (Independent Director)
Mr Bernard Tuch (Independent Director)
Mr Robert Moyse Willcocks (Independent Director)
Mr John Cowan (CFO)
Company Secretary Mr Nick Geddes
Principal Activities Living Cell Technologies: developing cell-based therapies for type 1 diabetes and neurological disorders.

LIVING CELL TECHNOLOGIES LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/10/2014   Notice of Annual General Meeting/Proxy Form 8 PDF
17/10/2014   Annual Report to shareholders 48 PDF
15/10/2014   Share Purchase Plan Offer Terms and Conditions 10 PDF
14/10/2014   Change in substantial holding 3 PDF
10/10/2014   Cleansing Statement 1 PDF
10/10/2014 asterix LCT JV secures funds to realise the potential of DIABECELL 2 PDF
08/10/2014   Appendix 3B 9 PDF
08/10/2014 asterix Completion of $3m placement and SPP announced 3 PDF
29/09/2014   LCT collaborates to develop novel neurological treatments 2 PDF
23/09/2014   LCT Appoints Scientific Advisors 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Oct 2014 0.061 -11.59% 0.069 0.061 176,311
21 Oct 2014 0.069 13.11% 0.071 0.067 511,184
20 Oct 2014 0.061 1.67% 0.061 0.061 30,000
16 Oct 2014 0.060 -6.25% 0.060 0.060 71,666
14 Oct 2014 0.064 -12.33% 0.072 0.064 72,587

* Volume of shares shown represents only those shares traded on ASX.

LIVING CELL TECHNOLOGIES LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security LCT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security LCT

Warrants & Structured Products

No warrants & Structured Products are available over the security LCT